Edaise M da Silva
Overview
Explore the profile of Edaise M da Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Feinberg J, Da Cruz Paula A, da Silva E, Pareja F, Patel J, Zhu Y, et al.
Gynecol Oncol
. 2024 Feb;
185:58-67.
PMID: 38368814
Objective: Adenoid cystic carcinoma (AdCC) of the Bartholin's gland (AdCC-BG) is a very rare gynecologic vulvar malignancy. AdCC-BGs are slow-growing but locally aggressive and are associated with high recurrence rates....
12.
Dopeso H, Gazzo A, Derakhshan F, Brown D, Selenica P, Jalali S, et al.
NPJ Precis Oncol
. 2024 Feb;
8(1):33.
PMID: 38347189
CDH1 (E-cadherin) bi-allelic inactivation is the hallmark alteration of breast invasive lobular carcinoma (ILC), resulting in its discohesive phenotype. A subset of ILCs, however, lack CDH1 genetic/epigenetic inactivation, and their...
13.
Chui M, Brown D, Da Cruz Paula A, da Silva E, Momeni-Boroujeni A, Reis-Filho J, et al.
J Pathol
. 2023 Nov;
262(2):129-136.
PMID: 38013631
Trastuzumab has demonstrated clinical efficacy in the treatment of HER2-positive serous endometrial cancer (EC), which led to its incorporation into standard-of-care management of this aggressive disease. Acquired resistance remains an...
14.
Derakhshan F, Da Cruz Paula A, Selenica P, da Silva E, Grabenstetter A, Jalali S, et al.
Mod Pathol
. 2023 Nov;
37(2):100375.
PMID: 37925055
CDH1 encodes for E-cadherin, and its loss of function is the hallmark of invasive lobular carcinoma (ILC). Albeit vanishingly rare, biallelic CDH1 alterations may be found in nonlobular breast carcinomas...
15.
Mandelker D, Marra A, Zheng-Lin B, Selenica P, Blanco-Heredia J, Zhu Y, et al.
J Clin Oncol
. 2023 Aug;
41(33):5151-5162.
PMID: 37607324
Purpose: To determine the genetic predisposition underlying pancreatic acinar cell carcinoma (PACC) and characterize its genomic features. Methods: Both somatic and germline analyses were performed using an Food and Drug...
16.
Boyraz B, Da Cruz Paula A, Deveraux K, Tran I, da Silva E, Young R, et al.
Am J Surg Pathol
. 2023 Aug;
47(11):1285-1290.
PMID: 37584555
Endometrial/endometrioid stromal tumors are rare and morphologically heterogenous, and their diagnosis may be challenging. We identified 3 endometrial/endometrioid stromal tumors with identical and previously undescribed histologic features and herein report...
17.
Yu J, da Silva E, La H, Clark B, Fine J, Carter G, et al.
NPJ Breast Cancer
. 2023 Jul;
9(1):60.
PMID: 37443169
This study describes "lobular-like invasive mammary carcinomas" (LLIMCas), a group of low- to intermediate-grade invasive mammary carcinomas with discohesive, diffusely infiltrative cells showing retained circumferential membranous immunoreactivity for both E-cadherin...
18.
Yu Y, Cao W, Cheng F, Shi Z, Han L, Yi J, et al.
bioRxiv
. 2023 Jul;
PMID: 37398114
Activation of oncogenes through DNA amplification/overexpression plays an important role in cancer initiation and progression. Chromosome 17 has many cancer-associated genetic anomalies. This cytogenetic anomaly is strongly associated with poor...
19.
Momeni Boroujeni A, Kertowidjojo E, Wu X, Soslow R, Chiang S, da Silva E, et al.
Mod Pathol
. 2022 Sep;
35(11):1684-1694.
PMID: 36138078
Mullerian adenosarcoma is an uncommon mesenchymal tumor of the gynecologic tract. Most cases are low-grade, while high-grade adenosarcomas are rare and not well studied. Herein, we characterize the clinicopathologic and...
20.
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma
Safdar N, Stasenko M, Selenica P, Martin A, da Silva E, Sebastiao A, et al.
J Natl Cancer Inst
. 2022 Jun;
114(11):1545-1548.
PMID: 35699480
Low-stage, low-grade endometrioid endometrial carcinoma (EEC), the most common histologic type of endometrial cancer, typically has a favorable prognosis. A subset of these cancers, however, displays an aggressive clinical course...